eGene Announces Financial Advisory Agreement with MBC Global
eGene Inc. has signed a one-year financial advisory agreement with MBC Global, LLC, an international merchant banking company located in Lake Forest, Ill. MBC Global facilitated the merger between Centroid Consolidated Mines Co. , which was a public company, and BioCal Technology Inc. (www.biocal.com), which was a privately held entity, and will assist the company in identifying, evaluating and developing potential mergers, acquisitions, strategic partnerships or other similar transactions. eGene raised $1.6 million in private funding prior to the close of the merger.
"We are excited to have MBC Global with us given their expertise in assisting us with our financial needs and with their significant contacts in the domestic and international markets," stated Dr. Udo Henseler, eGene's chief executive officer. "We look forward to their assistance as we work to take this company to the next level."
"We are very pleased with this opportunity to assist eGene Inc. in developing their capital structure and vision for the company's future and helping them with both their short-term and long-term objectives," commented Ric Landry, MBC Global's COO.
eGene Inc., a Nevada corporation, is an emerging biotech company competing in the biological/microbial materials and life sciences testing industries. It uses its core technologies of capillary electrophoresis, microfluidics, liquid handling and automation to create low-cost, leading-edge and novel genotyping DNA testing tools for the biological/microbial materials and life sciences testing industries. BioCal's strategy is to deliver applications and tools to these industries that it believes will have immediate commercial relevance. Its DNA HDA-GT12 system detects, quantifies, identifies and characterizes biological organisms, and automates routine and non-routine laboratory and industrial procedures critical to productivity.
Other news from the department business & finance
